<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">detinf</journal-id><journal-title-group><journal-title xml:lang="ru">ДЕТСКИЕ ИНФЕКЦИИ</journal-title><trans-title-group xml:lang="en"><trans-title>CHILDREN INFECTIONS</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-8107</issn><issn pub-type="epub">2618-8139</issn><publisher><publisher-name>Association of Pediatricians and Infection Disease doctors</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22627/2072-8107-2022-21-1-41-44</article-id><article-id custom-type="elpub" pub-id-type="custom">detinf-678</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>TO HELP OF PRACTICAL PEDIATRICS</subject></subj-group></article-categories><title-group><article-title>Изучение Т-клеточного иммунитета, интерфероногенеза, медиаторов воспаления у детей с инфекцией, вызванной вирусом Varicella zoster</article-title><trans-title-group xml:lang="en"><trans-title>Study of T-cell immunity, interferogenesis, inflammatory mediators in children with Varicella zoster virus infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9046-5802</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сабурова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Saburova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> аспирант</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Nizhny Novgorod </p></bio><email xlink:type="simple">Saburova.oxani@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3828-9316</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Собчак</surname><given-names>Д. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Sobchak</surname><given-names>D. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры инфекционных болезней</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p> MD, Professor </p><p> Nizhny Novgorod </p></bio><email xlink:type="simple">sobchak_devora@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2235-7644</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Отмахова</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Otmakhova</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>студент стоматологического факультета</p><p>Нижний Новгород</p></bio><bio xml:lang="en"><p>Nizhny Novgorod </p></bio><email xlink:type="simple">Otmachovaia@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Приволжский исследовательский медицинский университет<country>Россия</country></aff><aff xml:lang="en">Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>21</day><month>03</month><year>2022</year></pub-date><volume>21</volume><issue>1</issue><fpage>41</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сабурова О.А., Собчак Д.М., Отмахова К.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Сабурова О.А., Собчак Д.М., Отмахова К.А.</copyright-holder><copyright-holder xml:lang="en">Saburova O.A., Sobchak D.M., Otmakhova K.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://detinf.elpub.ru/jour/article/view/678">https://detinf.elpub.ru/jour/article/view/678</self-uri><abstract><p>Цель: Изучить содержание медиаторов иммунного ответа, показатели клеточного иммунитета у больных с инфекцией, вызванной вирусом Varicella Zoster с различными клинико-лабораторными показателями.Материалы и методы. Определение ДНК VZV методом полимеразной цепной реакции проводилось на базе ФБУН «Нижегородский научно-исследовательский институт эпидемиологии и микробиологии им. академика И.Н. Блохиной».Результаты исследования. Было показано, что у больных с опоясывающим герпесом (ОГ) значительно чаще регистрировалась ДНК VZV. У пациентов с ОГ содержание ИНФ-á, ИНФ-ã, CD-8+ было значительно ниже по сравнению с пациентами с неосложненным течением ветряной оспы.Обсуждение. У больных с ветряной оспой, осложненной бактериальной инфекцией, уровень ИЛ-1â и CD-4+ был значительно ниже по сравнению с соответствующими показателями при неосложненном течении болезни. Это подтверждало формирование слабого иммунного ответа у больных с осложненными формами ветряной оспы, что способствовало присоединению вторичной инфекции.Выводы. Снижение содержания медиаторов иммунного ответа и показателей клеточного иммунитета у детей с инфекцией, вызванной вирусом Varicella Zoster, свидетельствует о необходимости вакцинопрофилактики и профилактики бактериальных осложнений со стороны кожных покровов.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study. Determination of immune response mediators in patients with infection caused by the Varicella Zoster virus with various clinical and laboratory parameters.Materials and methods. Determination of VZV DNA by the polymerase reaction method. The blood content of proinflammatory mediators was assessed using the ELISA method using monoclonal antibodies (Protein contour, Petersburg).Research result. In patients with VZV the content of INF-α, INF-γ, CD-8+ was significantly lower than in patients with a typical form of the disease. In patients with a typical course of the disease, the DNA of the virus was less often determined.Discussion. In patients with pustular chickenpox, the level of IL-1β and CD-4+ was significantly lower than in the typical course of the disease.Conclusions. A decrease in the content of immune response mediators and indicators of cellular immunity in children with chickenpox is an indication for vaccination. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>varicella zoster</kwd><kwd>провоспалительные медиаторы</kwd><kwd>интерфероны</kwd><kwd>интерлейкины</kwd><kwd>клеточный иммунитет</kwd></kwd-group><kwd-group xml:lang="en"><kwd>varicella zoster</kwd><kwd>Pro-inflammatory mediators</kwd><kwd>interferons</kwd><kwd>cytokines</kwd><kwd>polymerase chain reaction</kwd><kwd>cellular immunity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kashyap S., Shanker V. Zoster ophthalmicus with dissemination in a six year old immunocompetent child. Indian J Dermatol Venereol Leprol, 2014; 80: 382.</mixed-citation><mixed-citation xml:lang="en">Kashyap S., Shanker V. Zoster ophthalmicus with dissemination in a six year old immunocompetent child. Indian J Dermatol Venereol Leprol, 2014; 80: 382.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Papaloukas O., Giannouli G., Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines, 2014; 2(2): 39—55.</mixed-citation><mixed-citation xml:lang="en">Papaloukas O., Giannouli G., Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines, 2014; 2(2): 39—55.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Singh P., Karmacharya S., Rizyal A., Rijal A.P. HZO with retrobulbar neuritis. Nepal J Ophthalmol, 2016; 8(15): 78—81.</mixed-citation><mixed-citation xml:lang="en">Singh P., Karmacharya S., Rizyal A., Rijal A.P. HZO with retrobulbar neuritis. Nepal J Ophthalmol, 2016; 8(15): 78—81.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Okunuki Y., Sakai J., Kezuka T., Goto H. A case of herpes zoster uveitis with severe hyphemia. BMC Ophthalmology, 2014; 14: 74.</mixed-citation><mixed-citation xml:lang="en">Okunuki Y., Sakai J., Kezuka T., Goto H. A case of herpes zoster uveitis with severe hyphemia. BMC Ophthalmology, 2014; 14: 74.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wakim L.M., Woodward A., Bevan M.J. Mamory T-cell persisting within the brain after local infection show functional to their tissue of residence. Proc. Nat. Acad. Sci USA, 2010; 107: 17872—17879.</mixed-citation><mixed-citation xml:lang="en">Wakim L.M., Woodward A., Bevan M.J. Mamory T-cell persisting within the brain after local infection show functional to their tissue of residence. Proc. Nat. Acad. Sci USA, 2010; 107: 17872—17879.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kawai K., Gebremeskel B.G., Acosta C.J. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open, 2014; 4(6): e004833.</mixed-citation><mixed-citation xml:lang="en">Kawai K., Gebremeskel B.G., Acosta C.J. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open, 2014; 4(6): e004833.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Paludan S.R., Horan K.A. Recognitin of herpesviruses by the innate immune system. Nat.Rev. Immunol, 2011; 11(2): 143—154.</mixed-citation><mixed-citation xml:lang="en">Paludan S.R., Horan K.A. Recognitin of herpesviruses by the innate immune system. Nat.Rev. Immunol, 2011; 11(2): 143—154.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen O.H., Ainsworth M.A. Tumor necrosis factor inhibitors for inflammatory bowel disease. New Engl. J. Med. 2013; 369: 754—762.</mixed-citation><mixed-citation xml:lang="en">Nielsen O.H., Ainsworth M.A. Tumor necrosis factor inhibitors for inflammatory bowel disease. New Engl. J. Med. 2013; 369: 754—762.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grinde B. Herpesviruses: latency and reactivation — viral strategies and host response. J Microbiol, 2013; 5: 227—266.</mixed-citation><mixed-citation xml:lang="en">Grinde B. Herpesviruses: latency and reactivation — viral strategies and host response. J Microbiol, 2013; 5: 227—266.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Winsauer C., Kruglov A.A., Chashchina A.A., Drutskaya M.S., Nedospasov S.A. Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice. Cytokine Growth Factor Rev. 2014; 25: 115—123.</mixed-citation><mixed-citation xml:lang="en">Winsauer C., Kruglov A.A., Chashchina A.A., Drutskaya M.S., Nedospasov S.A. Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice. Cytokine Growth Factor Rev. 2014; 25: 115—123.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
